Selcuk Ecza reports a circuit breaker: what it means for Selcuk Ecza stock

Published on 10/14/2026 at 02:58 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Profit reached TRY 2.18 billion after a TRY 421.7 million loss. For Selcuk Ecza stock this means TRY 109.0 billion in six-month sales.

Earnings and market context

A trading circuit-breaker notification was listed on October 12, 2026.
First-half net profit reached TRY 2.18 billion after a TRY 421.7 million loss.
Sales totaled TRY 109.0 billion for the six months ended June 30.

Selcuk Ecza, TRESLEC00014, Illustration mit AI erstellt.

Selcuk Ecza (ISIN TRESLEC00014) reported a circuit-breaker notification on October 12, 2026, while its first-half profit showed a sharp reversal from the prior-year loss. Yatirimci.AI listed the notification as the latest KAP item for Selcuk Ecza.

Circuit breaker dated October 12

The filing followed a period of heavy attention around SELEC shares and gives the stock a concrete regulatory-market event for investors to assess. The notification itself does not change the company business model, which centers on distributing medicines from manufacturers to pharmacies and hospitals.

Selcuk Ecza operates in healthcare distribution and also manages pharmaceutical storage facilities. The company profile lists 5,975 full-time employees and identifies Istanbul as its principal operating base.

What the profit means for margins

According to FVT, first-half 2026 net sales reached TRY 109.0 billion and net profit stood at TRY 2.2 billion. Yatirimci.AI reported a more precise net profit of TRY 2,181.9 million, compared with a TRY 421.7 million loss in the first half of 2025.

The comparison is more informative than the headline profit alone: Selcuk Ecza moved from a loss to a positive result, but the result still needs to be read alongside the scale of sales. First-half total assets stood at TRY 101.7 billion, according to the same financial summary.

Stock sits above its yearly low

The last quoted SELEC price on Borsa Istanbul was TRY 73.65 on October 13, 2026 at 6:09 p.m. TRT. The quoted 52-week range was TRY 66.35 to TRY 402.50, while market capitalization stood at TRY 45.7 billion.

That range places the share price near the lower end of its annual span, while the earnings reversal provides a separate operating benchmark. For investors, the key tension is the distance between a positive first-half result and the stock's position within its 52-week range.